DE2333841A1 - Chemische verbindung mit regenerierender wirkung auf tierische gewebe und sie enthaltende pharmazeutische zubereitungen - Google Patents
Chemische verbindung mit regenerierender wirkung auf tierische gewebe und sie enthaltende pharmazeutische zubereitungenInfo
- Publication number
- DE2333841A1 DE2333841A1 DE19732333841 DE2333841A DE2333841A1 DE 2333841 A1 DE2333841 A1 DE 2333841A1 DE 19732333841 DE19732333841 DE 19732333841 DE 2333841 A DE2333841 A DE 2333841A DE 2333841 A1 DE2333841 A1 DE 2333841A1
- Authority
- DE
- Germany
- Prior art keywords
- manganese
- chemical compound
- solution
- animal tissue
- pharmaceutical preparations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims description 10
- 239000000825 pharmaceutical preparation Substances 0.000 title claims description 6
- 230000001172 regenerating effect Effects 0.000 title claims description 4
- 239000011572 manganese Substances 0.000 claims description 11
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 8
- 229910052748 manganese Inorganic materials 0.000 claims description 7
- 208000027418 Wounds and injury Diseases 0.000 claims description 6
- 206010052428 Wound Diseases 0.000 claims description 5
- 150000002696 manganese Chemical class 0.000 claims description 3
- 230000003449 preventive effect Effects 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- BTXXTMOWISPQSJ-UHFFFAOYSA-N 4,4,4-trifluorobutan-2-one Chemical compound CC(=O)CC(F)(F)F BTXXTMOWISPQSJ-UHFFFAOYSA-N 0.000 claims 1
- BQACOLQNOUYJCE-FYZZASKESA-N Abietic acid Natural products CC(C)C1=CC2=CC[C@]3(C)[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1 BQACOLQNOUYJCE-FYZZASKESA-N 0.000 claims 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 150000001447 alkali salts Chemical class 0.000 claims 1
- 238000009109 curative therapy Methods 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 11
- 239000002253 acid Substances 0.000 description 8
- KGMSWPSAVZAMKR-UHFFFAOYSA-N Me ester-3, 22-Dihydroxy-29-hopanoic acid Natural products C1CCC(C(O)=O)(C)C2C1(C)C1CCC(=C(C)C)C=C1CC2 KGMSWPSAVZAMKR-UHFFFAOYSA-N 0.000 description 5
- KGMSWPSAVZAMKR-ONCXSQPRSA-N Neoabietic acid Chemical compound [C@H]1([C@](CCC2)(C)C(O)=O)[C@@]2(C)[C@H]2CCC(=C(C)C)C=C2CC1 KGMSWPSAVZAMKR-ONCXSQPRSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229940099596 manganese sulfate Drugs 0.000 description 3
- 235000007079 manganese sulphate Nutrition 0.000 description 3
- 239000011702 manganese sulphate Substances 0.000 description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000037390 scarring Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 244000064816 Brassica oleracea var. acephala Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- LUTSRLYCMSCGCS-BWOMAWGNSA-N [(3s,8r,9s,10r,13s)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,16-decahydrocyclopenta[a]phenanthren-3-yl] acetate Chemical compound C([C@@H]12)C[C@]3(C)C(=O)CC=C3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)C)C1 LUTSRLYCMSCGCS-BWOMAWGNSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- -1 amine salts Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 229940099607 manganese chloride Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000025 natural resin Substances 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7224414A FR2190438B1 (enrdf_load_stackoverflow) | 1972-07-06 | 1972-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2333841A1 true DE2333841A1 (de) | 1974-01-24 |
Family
ID=9101428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19732333841 Pending DE2333841A1 (de) | 1972-07-06 | 1973-07-03 | Chemische verbindung mit regenerierender wirkung auf tierische gewebe und sie enthaltende pharmazeutische zubereitungen |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS4948818A (enrdf_load_stackoverflow) |
| CH (1) | CH578499A5 (enrdf_load_stackoverflow) |
| DE (1) | DE2333841A1 (enrdf_load_stackoverflow) |
| ES (1) | ES416520A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2190438B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1436626A (enrdf_load_stackoverflow) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3670M (fr) * | 1964-03-25 | 1965-11-08 | Madaus & Co Dr | Nouveau médicament applicable par voie orale pour le traitement d'ulcérations chroniques des tissus. |
| FR1440750A (fr) * | 1965-04-20 | 1966-06-03 | Aquitaine Petrole | Copolymères d'oléfines avec des composés à noyau phénanthrénique |
-
1972
- 1972-07-06 FR FR7224414A patent/FR2190438B1/fr not_active Expired
-
1973
- 1973-07-02 CH CH958673A patent/CH578499A5/xx not_active IP Right Cessation
- 1973-07-03 DE DE19732333841 patent/DE2333841A1/de active Pending
- 1973-07-03 ES ES416520A patent/ES416520A1/es not_active Expired
- 1973-07-05 GB GB3217773A patent/GB1436626A/en not_active Expired
- 1973-07-06 JP JP48076477A patent/JPS4948818A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES416520A1 (es) | 1976-02-16 |
| FR2190438A1 (enrdf_load_stackoverflow) | 1974-02-01 |
| CH578499A5 (enrdf_load_stackoverflow) | 1976-08-13 |
| FR2190438B1 (enrdf_load_stackoverflow) | 1976-05-14 |
| GB1436626A (en) | 1976-05-19 |
| JPS4948818A (enrdf_load_stackoverflow) | 1974-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2605386C2 (de) | Aluminium-Zirkon-Komplexe zur Verwendung als Antitranspirantien | |
| DE2240782A1 (de) | Verfahren zur herstellung eines eisensaccharid-komplexes | |
| DE2129654B2 (de) | Medikament zur Verminderung der Kapillarpermeabilität und Erhöhung der Kapillarstabilität aus der Extraktion der Flavanole enthaltenden Früchte von Vitis vinifera | |
| DE2333841A1 (de) | Chemische verbindung mit regenerierender wirkung auf tierische gewebe und sie enthaltende pharmazeutische zubereitungen | |
| DE2542794A1 (de) | Molekulare verbindung aus allantoin und einem salz der 1- 2-pyrollidon-5-carboxylsaeure sowie verfahren zu ihrer herstellung | |
| DE2254663A1 (de) | Antimikrobische aluminiumhalogenidverbindungen enthaltende mischungen | |
| DE1915497A1 (de) | Arzneimittel mit hypolipidaemischer und hypocholesterinaemischer Wirksamkeit | |
| DE938502C (de) | Verfahren zur Herstellung einer kolloidalen Eisenzubereitung | |
| DE1936723C2 (de) | Salze von Chinarindenalkoloiden und Verfahren zu ihrer Herstellung | |
| DE1493618A1 (de) | Cumarinderivate und ein Verfahren zu ihrer Herstellung | |
| DE551421C (de) | Verfahren zur Darstellung von komplexen Goldverbindungen | |
| DE848955C (de) | Verfahren zur Herstellung von Mehrmetallkeratinsaeuren bzw. deren Alkali- oder Erdalkalisalzen | |
| DE193740C (enrdf_load_stackoverflow) | ||
| DE415095C (de) | Verfahren zur Herstellung einer in Wasser leicht loeslichen Wismutkomplexverbindung der Chinolinreihe | |
| AT217157B (de) | Verfahren zur Herstellung injizierbarer, wässeriger Suspensionen von amorphem Insulin | |
| DE646595C (de) | Verfahren zur Herstellung eines Abfuehrmittels | |
| AT110280B (de) | Verfahren zur Gewinnung von wasserlöslichen Anthrachinonglykosiden aus Drogen. | |
| EP0222198B1 (de) | Erzeugnisse enthaltend Amitriptylinoxid zur parenteralen Verabreichung bei der Therapie von Depressionen | |
| AT147483B (de) | Verfahren zur Darstellung von Verbindungen des N-Methyltetrahydronicotinsäuremethylesters. | |
| DE430684C (de) | Verfahren zur Herstellung einer basischen Trijodphenol-Wismutverbindung | |
| AT67205B (de) | Verfahren zur Herstellung eines Quecksilberpräparates, insbesondere für therapeutische Zwecke. | |
| DE1595951A1 (de) | Verfahren zur Herstellung von Desoxyuridinverbindungen | |
| AT362390B (de) | Verfahren zum verbessern von klinischem dextran | |
| DE655684C (de) | Verfahren zur Gewinnung von Metallverbindungen der Keratinsaeuren | |
| DE919602C (de) | Lichtschutzmittel |